Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8Head & Neck 6Gynecologic 5Genitourinary 4Breast 4Other hematologic neoplasm 3Lymphoid 3Thoracic 2Plasma cell 2Sarcoma 1Dermatologic 1CNS 1

Conditions

Melanoma 312Carcinoma, Basal Cell 60Skin Neoplasms 52Lymphoma, T-Cell, Cutaneous 37Breast Neoplasms 31Uveal Melanoma 29Neoplasms 27Lung Neoplasms 27Carcinoma, Non-Small-Cell Lung 27Keratosis, Actinic 25Neoplasm Metastasis 24Carcinoma, Squamous Cell 22Carcinoma, Renal Cell 21Lymphoma 17Mycosis Fungoides 16Lymphoma, Large B-Cell, Diffuse 15Hodgkin Disease 15Urinary Bladder Neoplasms 14Sezary Syndrome 14Pancreatic Neoplasms 14Lymphoma, Non-Hodgkin 14Lymphoma, Follicular 14Leukemia, Lymphocytic, Chronic, B-Cell 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Ovarian Neoplasms 13Lymphoma, Mantle-Cell 13Lymphoma, B-Cell, Marginal Zone 13Colorectal Neoplasms 13Burkitt Lymphoma 13Lymphoma, Large-Cell, Immunoblastic 12

Interventions

TH 302 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Hypoxia × Dermatologic × Clear all
NCT03098160 2017-10-30

Immunotherapy Study of Evofosfamide in Combination With Ipilimumab

Threshold Pharmaceuticals

Phase 1 Unknown
69 enrolled
DermatologicGastrointestinalGenitourinaryHead & Neck

Squamous Cell Carcinoma of Head and Neck, Hypoxia, Melanoma, Pancreatic Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡